These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7920888)

  • 1. Thiazolidinediones (AD-4833 and CS-045) improve hepatic insulin resistance in streptozotocin-induced diabetic rats.
    Tominaga M; Igarashi M; Daimon M; Eguchi H; Matsumoto M; Sekikawa A; Yamatani K; Sasaki H
    Endocr J; 1993 Jun; 40(3):343-9. PubMed ID: 7920888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of troglitazone on hepatic and peripheral insulin resistance induced by growth hormone excess in rats.
    Sugimoto M; Takeda N; Nakashima K; Okumura S; Takami K; Yoshino K; Hattori J; Ishimori M; Takami R; Sasaki A; Yasuda K
    Metabolism; 1998 Jul; 47(7):783-7. PubMed ID: 9667221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats.
    Yoshino K; Takeda N; Sugimoto M; Nakashima K; Okumura S; Hattori J; Sasaki A; Kawachi S; Takami K; Takami R; Yasuda K
    Metabolism; 1999 Nov; 48(11):1418-23. PubMed ID: 10582551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
    O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA
    Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and wistar fatty rats.
    Kimura M; Daimon M; Tominaga M; Manaka H; Sasaki H; Kato T
    Endocr J; 2000 Feb; 47(1):21-8. PubMed ID: 10811289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of troglitazone on exocrine pancreas in rats with streptozotocin-induced diabetes mellitus.
    Shimizu K; Shiratori K; Hayashi N; Fujiwara T; Horikoshi H
    Pancreas; 2000 Nov; 21(4):421-6. PubMed ID: 11075998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance.
    Miles PD; Higo K; Romeo OM; Lee MK; Rafaat K; Olefsky JM
    Diabetes; 1998 Mar; 47(3):395-400. PubMed ID: 9519745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of troglitazone on dexamethasone-induced insulin resistance in rats.
    Okumura S; Takeda N; Takami K; Yoshino K; Hattori J; Nakashima K; Sugimoto M; Ishimori M; Takami R; Yasuda K
    Metabolism; 1998 Mar; 47(3):351-4. PubMed ID: 9500576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone (CS-045) ameliorates albuminuria in streptozotocin-induced diabetic rats.
    Fujii M; Takemura R; Yamaguchi M; Hasegawa G; Shigeta H; Nakano K; Kondo M
    Metabolism; 1997 Sep; 46(9):981-3. PubMed ID: 9284882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatments for GH-induced insulin resistance.
    Sugimoto M; Takeda N; Hattori J; Yoshino K; Nakashima K; Okumura S; Ishimori M; Yasuda K
    Endocr J; 1999 Mar; 46 Suppl():S51-3. PubMed ID: 12054120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of troglitazone on fat-induced insulin resistance in the rat.
    Khoursheed M; Miles PD; Gao KM; Lee MK; Moossa AR; Olefsky JM
    Metabolism; 1995 Nov; 44(11):1489-94. PubMed ID: 7476339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.
    Lee MK; Miles PD; Khoursheed M; Gao KM; Moossa AR; Olefsky JM
    Diabetes; 1994 Dec; 43(12):1435-9. PubMed ID: 7958495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone: review and assessment of its role in the treatment of patients with impaired glucose tolerance and diabetes mellitus.
    Johnson MD; Campbell LK; Campbell RK
    Ann Pharmacother; 1998 Mar; 32(3):337-48. PubMed ID: 9533065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of troglitazone and voluntary running on insulin resistance induced high fat diet in the rat.
    Kitakoshi K; Oshida Y; Nakai N; Han YQ; Sato Y
    Horm Metab Res; 2001 Jun; 33(6):365-9. PubMed ID: 11456287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats.
    Shimabukuro M; Higa S; Shinzato T; Nagamine F; Komiya I; Takasu N
    Metabolism; 1996 Sep; 45(9):1168-73. PubMed ID: 8781306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance.
    Yagi N; Takasu N; Higa S; Ishikawa K; Murakami K; Mimura G
    Horm Metab Res; 1995 Oct; 27(10):439-41. PubMed ID: 8575720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.